Hmdb loader

Showing Protein mRNA decay activator protein ZFP36 (HMDBP13858)

IdentificationBiological propertiesGene propertiesProtein propertiesExternal linksReferencesXMLShow 0 metabolites
Identification
HMDB Protein ID HMDBP13858
Secondary Accession Numbers None
Name mRNA decay activator protein ZFP36
Synonyms
  1. Growth factor-inducible nuclear protein NUP475
  2. TPA-induced sequence 11
  3. Tristetraprolin
  4. Zinc finger protein 36
  5. Zfp-36
Gene Name ZFP36
Protein Type Unknown
Biological Properties
General Function Not Available
Specific Function Zinc-finger RNA-binding protein that destabilizes numerous cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis (PubMed:10330172, PubMed:10706852, PubMed:10805719, PubMed:15014438, PubMed:15187092, PubMed:15634918, PubMed:17030620, PubMed:19188452, PubMed:20595389, PubMed:21078877, PubMed:22701344, PubMed:27193233). Acts as an 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery (PubMed:21278420). Recruits deadenylase CNOT7 (and probably the CCR4-NOT complex) via association with CNOT1, and hence promotes ARE-mediated mRNA deadenylation (PubMed:21278420). Functions also by recruiting components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs (PubMed:21278420). Self regulates by destabilizing its own mRNA (PubMed:15187092, PubMed:17288565). Binds to 3'-UTR ARE of numerous mRNAs and of its own mRNA (PubMed:11533235, PubMed:15187092, PubMed:16508014, PubMed:17288565, PubMed:17971298, PubMed:20595389, PubMed:21078877, PubMed:21278420, PubMed:22701344, PubMed:27193233). Plays a role in anti-inflammatory responses; suppresses tumor necrosis factor (TNF)-alpha production by stimulating ARE-mediated TNF-alpha mRNA decay and several other inflammatory ARE-containing mRNAs in interferon (IFN)- and/or lipopolysaccharide (LPS)-induced macrophages (PubMed:8630730, PubMed:9703499, PubMed:15014438, PubMed:16514065). Plays also a role in the regulation of dendritic cell maturation at the post-transcriptional level, and hence operates as part of a negative feedback loop to limit the inflammatory response (By similarity). Promotes ARE-mediated mRNA decay of hypoxia-inducible factor HIF1A mRNA during the response of endothelial cells to hypoxia (By similarity). Positively regulates early adipogenesis of preadipocytes by promoting ARE-mediated mRNA decay of immediate early genes (IEGs) (PubMed:22701344). Negatively regulates hematopoietic/erythroid cell differentiation by promoting ARE-mediated mRNA decay of the transcription factor STAT5B mRNA (By similarity). Plays a role in maintaining skeletal muscle satellite cell quiescence by promoting ARE-mediated mRNA decay of the myogenic determination factor MYOD1 mRNA (PubMed:25815583). Associates also with and regulates the expression of non-ARE-containing target mRNAs at the post-transcriptional level, such as MHC class I mRNAs (By similarity). Participates in association with argonaute RISC catalytic components in the ARE-mediated mRNA decay mechanism; assists microRNA (miRNA) targeting ARE-containing mRNAs (By similarity). May also play a role in the regulation of cytoplasmic mRNA decapping; enhances decapping of ARE-containing RNAs, in vitro (By similarity). Involved in the delivery of target ARE-mRNAs to processing bodies (PBs) (By similarity). In addition to its cytosolic mRNA-decay function, affects nuclear pre-mRNA processing (PubMed:22844456). Negatively regulates nuclear poly(A)-binding protein PABPN1-stimulated polyadenylation activity on ARE-containing pre-mRNA during LPS-stimulated macrophages (PubMed:22844456). Also involved in the regulation of stress granule (SG) and P-body (PB) formation and fusion (PubMed:15967811). Plays a role in the regulation of keratinocyte proliferation, differentiation and apoptosis (By similarity). Plays a role as a tumor suppressor by inhibiting cell proliferation in breast cancer cells (By similarity).
Pathways
  • Human T-cell leukemia virus 1 infection
  • Kaposi sarcoma-associated herpesvirus infection
Reactions Not Available
GO Classification
Biological Process
regulation of tumor necrosis factor production
nuclear-transcribed mRNA poly(A) tail shortening
cellular response to epidermal growth factor stimulus
MAPK cascade
positive regulation of mRNA catabolic process
3'-UTR-mediated mRNA destabilization
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
regulation of mRNA stability
3'-UTR-mediated mRNA stabilization
negative regulation of myeloid cell differentiation
regulation of keratinocyte differentiation
negative regulation of erythrocyte differentiation
negative regulation of interleukin-2 production
miRNA mediated inhibition of translation
negative regulation of polynucleotide adenylyltransferase activity
negative regulation of viral transcription
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay
p38MAPK cascade
positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA
positive regulation of gene silencing by miRNA
positive regulation of intracellular mRNA localization
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening
regulation of keratinocyte apoptotic process
regulation of keratinocyte proliferation
RNA destabilization
positive regulation of fat cell differentiation
cellular response to lipopolysaccharide
negative regulation of transcription from RNA polymerase II promoter
cellular response to granulocyte macrophage colony-stimulating factor stimulus
intracellular signal transduction
response to wounding
cellular response to tumor necrosis factor
cellular response to glucocorticoid stimulus
multicellular organismal development
mRNA catabolic process
regulation of transcription from RNA polymerase II promoter
response to starvation
cellular response to fibroblast growth factor stimulus
negative regulation of inflammatory response
mRNA transport
Cellular Component
ribonucleoprotein complex
cytoplasmic mRNA processing body
nucleus
cytosol
cytoplasmic stress granule
cytoplasm
Molecular Function
mRNA 3'-UTR binding
metal ion binding
protein kinase binding
RNA polymerase binding
C-C chemokine binding
DNA binding
14-3-3 protein binding
enzyme binding
mRNA 3'-UTR AU-rich region binding
protein-containing complex binding
heat shock protein binding
mRNA binding
Cellular Location Not Available
Gene Properties
Chromosome Location Not Available
Locus Not Available
SNPs Not Available
Gene Sequence Not Available
Protein Properties
Number of Residues 319
Molecular Weight 33613.0
Theoretical pI 8.427
Pfam Domain Function
Signals Not Available
Transmembrane Regions Not Available
Protein Sequence Not Available
GenBank ID Protein Not Available
UniProtKB/Swiss-Prot ID P22893
UniProtKB/Swiss-Prot Entry Name TTP_MOUSE
PDB IDs
GenBank Gene ID Not Available
GeneCard ID Not Available
GenAtlas ID Not Available
HGNC ID Not Available
References
General References
  1. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [PubMed:15489334 ]
  2. Trost M, English L, Lemieux S, Courcelles M, Desjardins M, Thibault P: The phagosomal proteome in interferon-gamma-activated macrophages. Immunity. 2009 Jan 16;30(1):143-54. doi: 10.1016/j.immuni.2008.11.006. [PubMed:19144319 ]
  3. Carballo E, Lai WS, Blackshear PJ: Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science. 1998 Aug 14;281(5379):1001-5. doi: 10.1126/science.281.5379.1001. [PubMed:9703499 ]
  4. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, Blackshear PJ: Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol. 1999 Jun;19(6):4311-23. doi: 10.1128/MCB.19.6.4311. [PubMed:10330172 ]
  5. Ogilvie RL, Abelson M, Hau HH, Vlasova I, Blackshear PJ, Bohjanen PR: Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J Immunol. 2005 Jan 15;174(2):953-61. doi: 10.4049/jimmunol.174.2.953. [PubMed:15634918 ]
  6. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, Saklatvala J, Clark AR: Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol. 2006 Mar;26(6):2408-18. doi: 10.1128/MCB.26.6.2408-2418.2006. [PubMed:16508015 ]
  7. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ: Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol. 2006 Dec;26(24):9196-208. doi: 10.1128/MCB.00945-06. Epub 2006 Oct 9. [PubMed:17030620 ]
  8. Horner TJ, Lai WS, Stumpo DJ, Blackshear PJ: Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin. Mol Cell Biol. 2009 Apr;29(8):1999-2010. doi: 10.1128/MCB.00982-08. Epub 2009 Feb 2. [PubMed:19188452 ]
  9. Hacker C, Valchanova R, Adams S, Munz B: ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production. Growth Factors. 2010 Jun;28(3):178-90. doi: 10.3109/08977190903578660. [PubMed:20166898 ]
  10. Kedar VP, Darby MK, Williams JG, Blackshear PJ: Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85. PLoS One. 2010 Mar 8;5(3):e9588. doi: 10.1371/journal.pone.0009588. [PubMed:20221403 ]
  11. Clement SL, Scheckel C, Stoecklin G, Lykke-Andersen J: Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol Cell Biol. 2011 Jan;31(2):256-66. doi: 10.1128/MCB.00717-10. Epub 2010 Nov 15. [PubMed:21078877 ]
  12. Hausburg MA, Doles JD, Clement SL, Cadwallader AB, Hall MN, Blackshear PJ, Lykke-Andersen J, Olwin BB: Post-transcriptional regulation of satellite cell quiescence by TTP-mediated mRNA decay. Elife. 2015 Mar 27;4:e03390. doi: 10.7554/eLife.03390. [PubMed:25815583 ]
  13. Nowotarski SL, Origanti S, Sass-Kuhn S, Shantz LM: Destabilization of the ornithine decarboxylase mRNA transcript by the RNA-binding protein tristetraprolin. Amino Acids. 2016 Oct;48(10):2303-11. doi: 10.1007/s00726-016-2261-9. Epub 2016 May 19. [PubMed:27193233 ]
  14. Lai WS, Stumpo DJ, Blackshear PJ: Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem. 1990 Sep 25;265(27):16556-63. [PubMed:2204625 ]
  15. DuBois RN, McLane MW, Ryder K, Lau LF, Nathans D: A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. J Biol Chem. 1990 Nov 5;265(31):19185-91. [PubMed:1699942 ]
  16. Varnum BC, Lim RW, Sukhatme VP, Herschman HR: Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene. 1989 Jan;4(1):119-20. [PubMed:2915901 ]
  17. Ma Q, Herschman HR: A corrected sequence for the predicted protein from the mitogen-inducible TIS11 primary response gene. Oncogene. 1991 Jul;6(7):1277-8. [PubMed:1861870 ]
  18. Varnum BC, Ma QF, Chi TH, Fletcher B, Herschman HR: The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat. Mol Cell Biol. 1991 Mar;11(3):1754-8. doi: 10.1128/mcb.11.3.1754-1758.1991. [PubMed:1996120 ]
  19. Lai WS, Thompson MJ, Taylor GA, Liu Y, Blackshear PJ: Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin. J Biol Chem. 1995 Oct 20;270(42):25266-72. doi: 10.1074/jbc.270.42.25266. [PubMed:7559666 ]
  20. Taylor GA, Thompson MJ, Lai WS, Blackshear PJ: Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro. J Biol Chem. 1995 Jun 2;270(22):13341-7. doi: 10.1074/jbc.270.22.13341. [PubMed:7768935 ]
  21. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ: A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity. 1996 May;4(5):445-54. doi: 10.1016/s1074-7613(00)80411-2. [PubMed:8630730 ]
  22. Carballo E, Lai WS, Blackshear PJ: Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood. 2000 Mar 15;95(6):1891-9. [PubMed:10706852 ]
  23. Stoecklin G, Ming XF, Looser R, Moroni C: Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol Cell Biol. 2000 Jun;20(11):3753-63. doi: 10.1128/MCB.20.11.3753-3763.2000. [PubMed:10805719 ]
  24. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR: Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol. 2001 Oct;21(19):6461-9. doi: 10.1128/MCB.21.9.6461-6469.2001. [PubMed:11533235 ]
  25. Phillips RS, Ramos SB, Blackshear PJ: Members of the tristetraprolin family of tandem CCCH zinc finger proteins exhibit CRM1-dependent nucleocytoplasmic shuttling. J Biol Chem. 2002 Mar 29;277(13):11606-13. doi: 10.1074/jbc.M111457200. Epub 2002 Jan 16. [PubMed:11796723 ]
  26. Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, Blackwell TK, Anderson P: MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 2004 Mar 24;23(6):1313-24. doi: 10.1038/sj.emboj.7600163. Epub 2004 Mar 11. [PubMed:15014438 ]
  27. Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, Worthington MT, Sturgill TW: MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem. 2004 Mar 12;279(11):10176-84. doi: 10.1074/jbc.M310486200. Epub 2003 Dec 19. [PubMed:14688255 ]
  28. Tchen CR, Brook M, Saklatvala J, Clark AR: The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. J Biol Chem. 2004 Jul 30;279(31):32393-400. doi: 10.1074/jbc.M402059200. Epub 2004 Jun 7. [PubMed:15187092 ]
  29. Kedersha N, Stoecklin G, Ayodele M, Yacono P, Lykke-Andersen J, Fritzler MJ, Scheuner D, Kaufman RJ, Golan DE, Anderson P: Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol. 2005 Jun 20;169(6):871-84. doi: 10.1083/jcb.200502088. [PubMed:15967811 ]
  30. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M: Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol. 2006 Mar;26(6):2399-407. doi: 10.1128/MCB.26.6.2399-2407.2006. [PubMed:16508014 ]
  31. Lin NY, Lin CT, Chen YL, Chang CJ: Regulation of tristetraprolin during differentiation of 3T3-L1 preadipocytes. FEBS J. 2007 Feb;274(3):867-78. doi: 10.1111/j.1742-4658.2007.05632.x. [PubMed:17288565 ]
  32. Sun L, Stoecklin G, Van Way S, Hinkovska-Galcheva V, Guo RF, Anderson P, Shanley TP: Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem. 2007 Feb 9;282(6):3766-77. doi: 10.1074/jbc.M607347200. Epub 2006 Dec 14. [PubMed:17170118 ]
  33. Lin NY, Lin CT, Chang CJ: Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells. Biochem Biophys Res Commun. 2008 Jan 4;365(1):69-74. doi: 10.1016/j.bbrc.2007.10.119. Epub 2007 Oct 29. [PubMed:17971298 ]
  34. Marchese FP, Aubareda A, Tudor C, Saklatvala J, Clark AR, Dean JL: MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment. J Biol Chem. 2010 Sep 3;285(36):27590-600. doi: 10.1074/jbc.M110.136473. Epub 2010 Jul 1. [PubMed:20595389 ]
  35. Sandler H, Kreth J, Timmers HT, Stoecklin G: Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin. Nucleic Acids Res. 2011 May;39(10):4373-86. doi: 10.1093/nar/gkr011. Epub 2011 Jan 29. [PubMed:21278420 ]
  36. Lin NY, Lin TY, Yang WH, Wang SC, Wang KT, Su YL, Jiang YW, Chang GD, Chang CJ: Differential expression and functional analysis of the tristetraprolin family during early differentiation of 3T3-L1 preadipocytes. Int J Biol Sci. 2012;8(5):761-77. doi: 10.7150/ijbs.4036. Epub 2012 May 31. [PubMed:22701344 ]
  37. Su YL, Wang SC, Chiang PY, Lin NY, Shen YF, Chang GD, Chang CJ: Tristetraprolin inhibits poly(A)-tail synthesis in nuclear mRNA that contains AU-rich elements by interacting with poly(A)-binding protein nuclear 1. PLoS One. 2012;7(7):e41313. doi: 10.1371/journal.pone.0041313. Epub 2012 Jul 26. [PubMed:22844456 ]
  38. Tan FE, Elowitz MB: Brf1 posttranscriptionally regulates pluripotency and differentiation responses downstream of Erk MAP kinase. Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):E1740-8. doi: 10.1073/pnas.1320873111. Epub 2014 Apr 14. [PubMed:24733888 ]
  39. Fu R, Olsen MT, Webb K, Bennett EJ, Lykke-Andersen J: Recruitment of the 4EHP-GYF2 cap-binding complex to tetraproline motifs of tristetraprolin promotes repression and degradation of mRNAs with AU-rich elements. RNA. 2016 Mar;22(3):373-82. doi: 10.1261/rna.054833.115. Epub 2016 Jan 13. [PubMed:26763119 ]
  40. Amann BT, Worthington MT, Berg JM: A Cys3His zinc-binding domain from Nup475/tristetraprolin: a novel fold with a disklike structure. Biochemistry. 2003 Jan 14;42(1):217-21. doi: 10.1021/bi026988m. [PubMed:12515557 ]